Nitrolingual patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7872049 POHL BOSKAMP Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate
Mar, 2029

(5 years from now)

Nitrolingual is owned by Pohl Boskamp.

Nitrolingual contains Nitroglycerin.

Nitrolingual has a total of 1 drug patent out of which 0 drug patents have expired.

Nitrolingual was authorised for market use on 31 October, 1985.

Nitrolingual is available in spray, metered;sublingual dosage forms.

Nitrolingual can be used as method of treating angina pectoris.

The generics of Nitrolingual are possible to be released after 12 March, 2029.

Drugs and Companies using NITROGLYCERIN ingredient

Market Authorisation Date: 31 October, 1985

Treatment: Method of treating angina pectoris


How can I launch a generic of NITROLINGUAL before it's drug patent expiration?
More Information on Dosage

NITROLINGUAL family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic